Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07123116) titled 'Shenbai Granules for Preventing Recurrence of Low-Risk Colorectal Adenomas' on Aug. 8.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Jiangsu Famous Medical Technology Co., Ltd.
Condition:
Colorectal Adenoma
TCM
Low Risk
Intervention:
Drug: Shenbai Granules
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: August 15, 2025
Target Sample Size: 450
Countries of Recruitment:
China
To know more, visit...